MAPP Financial Facts
Sales, general and administrative: 5.64MTotal operating expenses: 13.5M
See Full Income Statement
Balance Sheet Components: 0
See Full Balance Sheet
MAP Pharmaceuticals, Inc. (MAPP) Earnings
|
Expand Research on MAPP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -29.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/4/12 | Q112 | -$0.58 | -$0.39 | -$0.19 | $1M | $1.1M | N/A |  | | Details | |
| 3/29/12 | Q411 | -$0.45 | -$0.31 | -$0.14 | $837K | $2.74M | N/A | | | Details | |
8/4/11  |
Q211 | -$0.28 | -$0.38 | +$0.10 | $3.5M | $2.55M | N/A | | | Details | |
| 5/3/11 |
Q111 | -$0.58 | -$0.39 | -$0.19 | $34.2M | $820K | N/A | | | Details | |
| 3/1/11 | Q410 | -$0.46 | -$0.44 | -$0.02 | N/A | N/A | N/A | | | Details |
